WHO ICTRP trial
A randomized, double blind, placebo-controlled, parallel group, pilot study to…
ACTRN12615000094572 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12615000094572 |
|---|---|
| Public title | A randomized, double blind, placebo-controlled, parallel group, pilot study to assess the safety and efficacy of a therapeutic Herpes Simplex Virus-2 (HSV-2) Deoxyribonucleic Acid (DNA) vaccine in HSV-2 positive adults |
| Scientific title | A Phase l/IIa, randomized, double blind, placebo-controlled, parallel group, pilot study to assess the safety and efficacy of a therapeutic HSV-2 DNA vaccine in HSV-2 positive adults |
| Primary sponsor | Admedus Vaccines Pty Ltd |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 1 / Phase 2 |
| Countries | Australia |
| Conditions | Genital Herpes; Genital Herpes;Infection - Sexually transmitted infections |
| Interventions | HSV-2 DNA Vaccine Two injection regimens of the HSV-2 DNA vaccine will be compared with placebo, administered by intradermal injection as three, 4-weekly doses followed by a 6-month booster. The first injection regime will consist of… |
| Registration date | Apr 2, 2015 |
| Target size | 40 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: